Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 306, Issue 9, 2014, Pages

  Johansson, Sofie L ^a   Tan, Qihua ^a,b   Holst, René ^a   Christiansen, Lene ^a,b   Hansen, Niels C G ^b   Hojland, Allan T ^a,c   Wulf Johansson, Helle ^a   Schlosser, Anders ^a   Titlestad, Ingrid L ^b   Vestbo, Jørgen ^b   Holmskov, Uffe ^a   Kyvik, Kirsten O ^a,b   Sorensen, Grith L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Forced expiratory volume in one second; Lung injury; Single nucleotide polymorphisms; Surfactant protein D; Tobacco smoking

Indexed keywords

BIOLOGICAL MARKER; SURFACTANT PROTEIN D; TOBACCO SMOKE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HERITABILITY; HUMAN; LUNG FUNCTION TEST; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO SMOKE INDUCED LUNG DAMAGE; TWINS;

FORCED EXPIRATORY VOLUME IN ONE SECOND; LUNG INJURY; SINGLE-NUCLEOTIDE POLYMORPHISMS; SURFACTANT PROTEIN D; TOBACCO SMOKING;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANTS; SMOKING; VITAL CAPACITY; YOUNG ADULT;

EID: 84900535443     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00340.2013     Document Type: Article

References (33)

1. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 19: 716-723, 1978.
2. American Thoracic Society. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152: 1107-1136, 1995.
3. Benyamin B, Sorensen TI, Schousboe K, Fenger M, Visscher PM, Kyvik KO. Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome? Diabetologia 50: 1880-1888, 2007.
4. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 115: 195-205, 1977.
5. Coxson HO, Dirksen A, Edwards LD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Crim C, Duvoix A, Fauerbach PN, Lomas DA, Macnee W, Mayer RJ, Miller BE, Muller NL, Rennard SI, Silverman EK, Tal-Singer R, Wouters EF, Vestbo J, Evaluation of CLtIPSEI. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 1: 129-136, 2013.
6. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 374: 1171-1178, 2009.
7. Dusser D, Bravo ML, Iacono P. The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J 27: 547-555, 2006.
8. Engstrom G, Lindberg C, Gerhardsson de Verdier M, Nihlen U, Anderson M, Svartengren M, Forsman-Semb K. Blood biomarkers and measures of pulmonary function-a study from the Swedish twin registry. Respir Med 106: 1250-1257, 2012.
9. Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, Bakke P, Gulsvik A, Lomas DA, Litonjua AA, Shapiro SD, Tal-Singer R, Silverman EK. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 44: 316-322, 2011.
10. Heidinger K, Konig IR, Bohnert A, Kleinsteiber A, Hilgendorff A, Gortner L, Ziegler A, Chakraborty T, Bein G. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced. Immunogenetics 57: 1-7, 2005.
11. Holst K, Scheike T. METS Package: Analysis of Multivariate Event Times. Vienna, Austria: CRAN, 2012.
12. Hubert HB, Fabsitz RR, Feinleib M, Gwinn C. Genetic and environmental influences on pulmonary function in adult twins. Am Rev Respir Dis 125: 409-415, 1982.
13. Ingebrigtsen TS, Thomsen SF, van der Sluis S, Miller M, Christensen K, Sigsgaard T, Backer V. Genetic influences on pulmonary function: a large sample twin study. Lung 189: 323-330, 2011.
14. Ishii T, Hagiwara K, Ikeda S, Arai T, Mieno MN, Kumasaka T, Muramatsu M, Sawabe M, Gemma A, Kida K. Association between genetic variations in surfactant protein D and emphysema, interstitial pneumonia, and lung cancer in a Japanese population. COPD 9: 409-416, 2012.
15. Ishii T, Hagiwara K, Kamio K, Ikeda S, Arai T, Mieno MN, Kumasaka T, Muramatsu M, Sawabe M, Gemma A, Kida K. Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet 20: 230-235, 2012.
16. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J. Efficacy of salmeterol/ fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 10: 59, 2009.
17. Jobe A, Ikegami M, Jacobs H, Jones S, Conaway D. Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol 55: 169-176, 1983.
18. Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agusti A, Wouters E, Celli B, Coxson H, Vestbo J, Macnee W, Yates JC, Rennard S, Litonjua A, Qiu W, Beaty TH, Crapo JD, Riley JH, Tal-Singer R, Silverman EK. Genome-wide Association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 1238-1247, 2012.
19. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 186: 975-981, 2012.
20. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J, Tornoe I, Madsen HO, Sorensen G, Crouch E, Holmskov U. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 174: 1532-1538, 2005.
21. Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 34: 95-102, 2009.
22. More JM, Voelker DR, Silveira LJ, Edwards MG, Chan ED, Bowler RP. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 10: 53, 2010.
23. Nybo M, Andersen K, Sorensen GL, Lolk A, Kragh-Sorensen P, Holmskov U. Serum surfactant protein D is correlated to development of dementia and augmented mortality. Clin Immunol 123: 333-337, 2007.
24. Olesen HV, Holmskov U, Schiotz PO, Sorensen GL. Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis. J Cyst Fibros 9: 257-262, 2010.
25. Palmer LJ, Knuiman MW, Divitini ML, Burton PR, James AL, Bartholomew HC, Ryan G, Musk AW. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur Respir J 17: 696-702, 2001.
26. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schunemann H, Wedzicha W, MacDonald R, Shekelle P. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155: 179-191, 2011.
27. Schousboe K, Visscher PM, Erbas B, Kyvik KO, Hopper JL, Henriksen JE, Heitmann BL, Sorensen TI. Twin study of genetic and environmental influences on adult body size, shape, and composition. Int J Obes Relat Metab Disord 28: 39-48, 2004.
28. Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 1207-1214, 2008.
29. Sorensen GL, Hjelmborg JB, Kyvik KO, Fenger M, Hoj A, Bendixen C, Sorensen TI, Holmskov U. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 290: L1010-L1017, 2006.
30. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212: 381-416, 2007.
31. Therneau T, Atkinson E, Sinnwell J, Matsumoto M, Schaid D, McDonnell S. Kinship2: Pedigree Functions. Vienna, Austria: CRAN, 2013.
32. Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 12: 29, 2011.
33. Wulf-Johansson H, Thinggaard M, Tan Q, Johansson SL, Schlosser A, Christensen K, Holmskov U, Sorensen GL. Circulating surfactant protein D is associated to mortality in elderly women: A twin study. Immunobiology 218: 712-717, 2012.